Clinical Trials Browser

Prostatic Neoplasms × Arsenic Trioxide × Genitourinary × Clear all

NCT00004149 2018-08-17

Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy

Phase 2 Completed

Prostatic Neoplasms